title: [The utilization of omegalicin in treatment of psoriasis].
abstract: The correcting action of omegalicin against the background of conventional treatment of psoriasis was investigated. It is established that omegalicin moderately increases the generation of active forms of oxygen needed to suppress the processes of proliferation at the expense of changing the activity of catalase, superoxide dismutase and glutathione peroxidase.
authors: R N
authors: RN
authors: Pavlova
authors: L A
authors: LA
authors: Kariakina
authors: Ch R
authors: ChR
authors: Beĭshebaeva
authors: V A
authors: VA
authors: Dadali
mesh_terms: D001205:Ascorbic Acid / Q000008:administration & dosage; D002374:Catalase / Q000187:drug effects; D004220:Disulfides; D004790:Enzyme Induction / Q000187:drug effects; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D005979:Glutathione Peroxidase / Q000187:drug effects; D006801:Humans; D008315:Malondialdehyde / Q000097:blood; D010084:Oxidation-Reduction / Q000187:drug effects*; D010100:Oxygen / Q000378:metabolism; D011565:Psoriasis / Q000628:therapy*; D013438:Sulfhydryl Compounds / Q000097:blood; D013441:Sulfinic Acids / Q000008:administration & dosage*; D013482:Superoxide Dismutase / Q000187:drug effects
chemical_list: D004220:Disulfides; D015525:Fatty Acids, Omega-3; D013438:Sulfhydryl Compounds; D013441:Sulfinic Acids; C006452:allicin; D008315:Malondialdehyde; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D001205:Ascorbic Acid; D010100:Oxygen